Teesside’s first cancer and molecular diagnostics graduates in Sri Lanka

Teesside University has celebrated graduation of the first cohort of students from its MSc Cancer and Molecular Diagnostics programme delivered through its transnational education partnership with the Business Management School (BMS) Sri Lanka.

It marks a significant achievement for both institutions, reflecting their shared commitment to developing highly skilled healthcare and biomedical professionals equipped to address some of the most pressing challenges in modern healthcare.

Designed to provide advanced knowledge and practical expertise in cancer biology, molecular diagnostics and precision medicine, the MSc programme combines cutting-edge scientific theory with applied research. The course prepares graduates for careers across clinical diagnostics, biomedical research, healthcare innovation and related fields.

Mohashi Munasinghe, MD, who was among the first cohort of graduates, said: “Building on my medical background, the Teesside MSc in Cancer and Molecular Diagnostics allowed me to sharpen my expertise in cancer research and diagnostics. Through rigorous lab work, data analysis, and mentorship from the BMS faculty, I developed a strong foundation in cancer biomarkers. I am excited to take the next step, pursuing doctoral studies to drive meaningful advancements in clinical cancer research.”

The inaugural cohort achieved exceptional academic success, with seven of the ten graduating students awarded distinctions. Many students also produced research projects of a standard suitable for publication, demonstrating the high calibre of work undertaken throughout the programme.

The programme is delivered through Teesside University's long-standing partnership with BMS Sri Lanka, which has expanded opportunities for students in the region to access internationally recognised postgraduate education while remaining in their home country.

Dr Mathi Kandiah, Dean, Faculty of Life and Medical Science, BMS Campus Sri Lanka, said: “The success of this first graduating cohort is a testament to the strength of the collaboration between BMS Campus Sri Lanka and Teesside University, as well as the amazing support, expertise, and resources provided by Teesside University. This unique partnership reflects a truly collaborative approach, ensuring that students in Sri Lanka receive great learning experience that has contributed to their excellent academic performance. The achievements of our graduates demonstrate the transformative impact that advanced scientific education can have on individuals, communities, and the wider healthcare sector.”

Dr Kevin Thomas, Associate Dean (International), School of Health & life Sciences, Teesside University, said: "We are delighted to celebrate this milestone with our partners at BMS Sri Lanka. The outstanding performance of this first cohort reflects the students' commitment to excellence and the quality of teaching and support available through the programme. Cancer and molecular diagnostics are rapidly evolving fields that play a critical role in improving patient outcomes, and we are proud to be helping develop the next generation of specialists in this area.”

As the partnership continues to grow, Teesside University and BMS Sri Lanka remain committed to delivering high-quality postgraduate education and supporting students to develop the knowledge, skills and research capabilities needed to make a meaningful contribution to healthcare and scientific advancement.

---